<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01565915</url>
  </required_header>
  <id_info>
    <org_study_id>MA-1400-05</org_study_id>
    <nct_id>NCT01565915</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Perlane-L in the Correction of Midface Volume Deficit</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medicis Global Service Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medicis Global Service Corporation</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if Perlane-L is safe in increasing cheek volume.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Facial fullness using midface scale</measure>
    <time_frame>Week 8</time_frame>
    <description>Change in facial fullness using midface scale.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Facial fullness using the midface scale</measure>
    <time_frame>Up to 12-months post treatment</time_frame>
    <description>Change in facial fullness using midface scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject satisfaction using the GAIS</measure>
    <time_frame>Up to 12-months post treatment</time_frame>
    <description>Compare treatment satisfaction as compared to no treatment, on the Global Aesthetic Improvement Scale (GAIS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aesthetic improvement</measure>
    <time_frame>Up to 12-months post treatment</time_frame>
    <description>A subjective assessment of aesthetic improvement post baseline</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">221</enrollment>
  <condition>Facial Volume</condition>
  <arm_group>
    <arm_group_label>Perlane-L</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Perlane-L treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-Treatment</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Non-Treatment Arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Perlane-L</intervention_name>
    <description>Perlane-L Injection in the midface</description>
    <arm_group_label>Perlane-L</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non-treatment</intervention_name>
    <description>Non-treatment Arm</description>
    <arm_group_label>Non-Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Loss of Fullness in Midface Area

          -  Other items as identified in the protocol

        Exclusion Criteria:

          -  History of allergy or hypersensitivity to injectable hyaluronic acid gel or lidocaine.

          -  Other items as identified in the protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <address>
        <city>Beverly Hills</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Vista</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Aventura</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Coral Gables</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hunt Valley</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chestnut Hill</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mount Kisco</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New York</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Eugene</city>
        <state>Oregon</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 12, 2012</study_first_submitted>
  <study_first_submitted_qc>March 27, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 29, 2012</study_first_posted>
  <last_update_submitted>August 20, 2013</last_update_submitted>
  <last_update_submitted_qc>August 20, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 21, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

